Research
Research News
Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the selection of Hematology and Oncology Fellow Fayez Estephan, MD, as the 2022 recipient of the Albert L. and Elizabeth T. Tucker Postdoctoral Fellowship for his research project titled, “Her-2…
Vsevolod “Seva” Polotsky, MD, has been selected to serve as vice chair for research in the Department of Anesthesiology and Critical Care Medicine at the George Washington University (GW) School of Medicine and Health Sciences and the GW Medical Faculty Associates. Polotsky will also serve as…